Skip to main content
Cardinal Health Inc.
Healthcare · Medical Distribution
Made on Aug 16, 2026
Price at call $235.17
6-month call Bull +12.7%
Target by Feb 2027 $265.00
Great value below $195.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change +12.7% to $265.00
Predicted High $265.00 at 6 months
Predicted Low $238.50 in 2 weeks

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 16, 2026 12:32 am
Bull CAH trends higher to $265.00 (+12.7% from $235.17) by Feb 2027. ride-then-fade
ThesisCAH is a low-beta compounder quietly making highs on consistent EPS beats, with a risk-on tape and fair-value composite near spot. Momentum plus 5-of-5 beat cadence supports a drift higher toward the signal-adjusted $290 anchor over 6 months, though value gravity from the anchored-PE at $188 caps the pace.
Invalidated ifA close below $215 (breaking recent breakout) or regime flip to risk-off would invalidate the drift-higher path.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $235.17 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 16, 2026 $235.17 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 30, 2026 $224.56–$245.78 typical range · internal point $238.50 ±4.5% 7/10 Momentum and risk-on tape extend record-high drift
1 month Sep 16, 2026 $219.80–$250.54 typical range · internal point $242.00 ±6.5% 6/10 Low-beta compounder continues quiet grind higher
2 months Oct 16, 2026 $248.00 +5.5% 5/10 Pre-earnings positioning, healthcare defensives bid
3 months Nov 16, 2026 $255.00 +8.4% 5/10 Likely Q1 beat extends 5-of-5 streak
4 months Dec 16, 2026 $258.00 +9.7% 4/10 Year-end consolidation near composite fair value
5 months Jan 16, 2027 $262.00 +11.4% 4/10 January drift toward signal-adjusted anchor
6 months Feb 16, 2027 $265.00 +12.7% 3/10 Convergence toward baseline endpoint, value gravity slows

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $261.97 (+11.4%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$235.17
Composite fair value$238.62
Signal-adjusted fair value$289.97
DCF fair value$332.49
Anchored-PE fair value$188.06
Buy-below (value lens)$195.00
Value net score-33
Value confidence6 / 10
Quality net score+49
Memo confidence6 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 24.4%  3m 22.6%  6m 24.7%  
Daily σ (realism noise)1.4%
Beta vs S&P 500 1m 0.17  3m -0.13  5m -0.01  
Trailing 6-month return9.4%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 16, 2026 freshest CAH-20260816-000829-3d0b
ext-lens-quality Aug 16, 2026 freshest ext-CAH-20260816-002430-ec88
ext-lens-sentiment Aug 16, 2026 freshest ext-CAH-20260816-002430-ec88
ext-lens-value Aug 16, 2026 freshest ext-CAH-20260816-002430-ec88
valuation-synthesis Aug 16, 2026 freshest CAH-20260816-000829-3d0b

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 16, 2026 v0.6.0 Bull $235.17 $265.00 +12.7% Feb 2027 viewing
Jul 20, 2026 v0.3.0 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.